Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 May;150(5):1583–1593.

Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation.

A Greiner 1, C Knörr 1, Y Qin 1, W Sebald 1, A Schimpl 1, J Banchereau 1, H K Müller-Hermelink 1
PMCID: PMC1858212  PMID: 9137085

Abstract

To investigate the mechanisms of T cell dependence underlying the development of extranodal mucosa-associated lymphoid tissue (MALT)-type B cell lymphomas, the activation, proliferation, and differentiation of lymphoma B cells were studied using ligand binding to the CD40 membrane receptor. The activation and proliferative response of all investigated low-grade MALT-type lymphomas (n = 6) was strongly dependent on anti-CD40-mediated signals and was complemented by cytokines produced by T helper cells of the Th2 type (interleukin-4 (IL-4) and/or IL-10). Th1 cytokines (IL-2 and/or interferon-gamma) bad little effect. Low-grade, but less so high-grade, MALT-type lymphoma B cells were induced to secrete large amounts of tumor immunoglobulin in response to IL-10. In contrast, high-grade MALT-type lymphomas (n = 5) proliferated in response to both Th2- and Th1-type cytokines and CD40 stimulation, whereas Burkitt lymphomas (n = 3) could not be rescued from apoptosis by CD40 stimulation with or without cytokines. These results suggest that CD40 signaling in combination with Th2 cytokines are essential for the development and progression of low-grade MALT-type B cell lymphoma. We conclude that T cells, which activate B cells in a CD40-dependent fashion, may contribute to lymphoma pathogenesis.

Full text

PDF
1585

Images in this article

1586Figure 1
on p.1586
1587Figure 2
on p.1587
1588Figure 3
on p.1588
1589Figure 4
on p.1589
1589Figure 5
on p.1589

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage R. J., Macduff B. M., Spriggs M. K., Fanslow W. C. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol. 1993 May 1;150(9):3671–3680. [PubMed] [Google Scholar]
  2. Arpin C., Déchanet J., Van Kooten C., Merville P., Grouard G., Brière F., Banchereau J., Liu Y. J. Generation of memory B cells and plasma cells in vitro. Science. 1995 May 5;268(5211):720–722. doi: 10.1126/science.7537388. [DOI] [PubMed] [Google Scholar]
  3. Banchereau J., Bazan F., Blanchard D., Brière F., Galizzi J. P., van Kooten C., Liu Y. J., Rousset F., Saeland S. The CD40 antigen and its ligand. Annu Rev Immunol. 1994;12:881–922. doi: 10.1146/annurev.iy.12.040194.004313. [DOI] [PubMed] [Google Scholar]
  4. Banchereau J., Rousset F. Growing human B lymphocytes in the CD40 system. Nature. 1991 Oct 17;353(6345):678–679. doi: 10.1038/353678a0. [DOI] [PubMed] [Google Scholar]
  5. Bateman A. C., Wright D. H. Epitheliotropism in high-grade lymphomas of mucosa-associated lymphoid tissue. Histopathology. 1993 Nov;23(5):409–415. doi: 10.1111/j.1365-2559.1993.tb00488.x. [DOI] [PubMed] [Google Scholar]
  6. Bayerdörffer E., Neubauer A., Rudolph B., Thiede C., Lehn N., Eidt S., Stolte M. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet. 1995 Jun 24;345(8965):1591–1594. doi: 10.1016/s0140-6736(95)90113-2. [DOI] [PubMed] [Google Scholar]
  7. Brière F., Servet-Delprat C., Bridon J. M., Saint-Remy J. M., Banchereau J. Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. J Exp Med. 1994 Feb 1;179(2):757–762. doi: 10.1084/jem.179.2.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Burdin N., Van Kooten C., Galibert L., Abrams J. S., Wijdenes J., Banchereau J., Rousset F. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol. 1995 Mar 15;154(6):2533–2544. [PubMed] [Google Scholar]
  9. Carbone A., Gloghini A., Gattei V., Aldinucci D., Degan M., De Paoli P., Zagonel V., Pinto A. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood. 1995 Feb 1;85(3):780–789. [PubMed] [Google Scholar]
  10. Cheng G., Cleary A. M., Ye Z. S., Hong D. I., Lederman S., Baltimore D. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science. 1995 Mar 10;267(5203):1494–1498. doi: 10.1126/science.7533327. [DOI] [PubMed] [Google Scholar]
  11. Dunn-Walters D. K., Isaacson P. G., Spencer J. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J Exp Med. 1995 Aug 1;182(2):559–566. doi: 10.1084/jem.182.2.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Durie F. H., Foy T. M., Masters S. R., Laman J. D., Noelle R. J. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today. 1994 Sep;15(9):406–411. doi: 10.1016/0167-5699(94)90269-0. [DOI] [PubMed] [Google Scholar]
  13. Fluckiger A. C., Garrone P., Durand I., Galizzi J. P., Banchereau J. Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J Exp Med. 1993 Nov 1;178(5):1473–1481. doi: 10.1084/jem.178.5.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fox R. I., Kang H. I., Ando D., Abrams J., Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol. 1994 Jun 1;152(11):5532–5539. [PubMed] [Google Scholar]
  15. Funakoshi S., Longo D. L., Beckwith M., Conley D. K., Tsarfaty G., Tsarfaty I., Armitage R. J., Fanslow W. C., Spriggs M. K., Murphy W. J. Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood. 1994 May 15;83(10):2787–2794. [PubMed] [Google Scholar]
  16. Graf D., Korthäuer U., Mages H. W., Senger G., Kroczek R. A. Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol. 1992 Dec;22(12):3191–3194. doi: 10.1002/eji.1830221226. [DOI] [PubMed] [Google Scholar]
  17. Greiner A., Kirchner T., Ott G., Marx A., Fischbach W., Müller-Hermelink H. K. Occurrence of multiple lymphoepithelioma-like carcinomas and MALT-type lymphoma in the stomach: detection of EBV in carcinomas but not in lymphoma. Histopathology. 1996 Jul;29(1):51–56. doi: 10.1046/j.1365-2559.1996.d01-482.x. [DOI] [PubMed] [Google Scholar]
  18. Greiner A., Marx A., Heesemann J., Leebmann J., Schmausser B., Müller-Hermelink H. K. Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest. 1994 Apr;70(4):572–578. [PubMed] [Google Scholar]
  19. Greiner A., Marx A., Schmausser B., Müller-Hermelink H. K. The pivotal role of the immunoglobulin receptor of tumor cells from B cell lymphomas of mucosa associated lymphoid tissue (MALT). Adv Exp Med Biol. 1994;355:189–193. doi: 10.1007/978-1-4615-2492-2_32. [DOI] [PubMed] [Google Scholar]
  20. Grouard G., de Bouteiller O., Banchereau J., Liu Y. J. Human follicular dendritic cells enhance cytokine-dependent growth and differentiation of CD40-activated B cells. J Immunol. 1995 Oct 1;155(7):3345–3352. [PubMed] [Google Scholar]
  21. Han S., Hathcock K., Zheng B., Kepler T. B., Hodes R., Kelsoe G. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J Immunol. 1995 Jul 15;155(2):556–567. [PubMed] [Google Scholar]
  22. Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994 Sep 1;84(5):1361–1392. [PubMed] [Google Scholar]
  23. Hiroi T., Fujihashi K., McGhee J. R., Kiyono H. Polarized Th2 cytokine expression by both mucosal gamma delta and alpha beta T cells. Eur J Immunol. 1995 Oct;25(10):2743–2751. doi: 10.1002/eji.1830251005. [DOI] [PubMed] [Google Scholar]
  24. Hodgkin P. D., Basten A. B cell activation, tolerance and antigen-presenting function. Curr Opin Immunol. 1995 Feb;7(1):121–129. doi: 10.1016/0952-7915(95)80037-9. [DOI] [PubMed] [Google Scholar]
  25. Hsu S. M., Waldron J. W., Jr, Hsu P. L., Hough A. J., Jr Cytokines in malignant lymphomas: review and prospective evaluation. Hum Pathol. 1993 Oct;24(10):1040–1057. doi: 10.1016/0046-8177(93)90183-h. [DOI] [PubMed] [Google Scholar]
  26. Hussell T., Isaacson P. G., Crabtree J. E., Dogan A., Spencer J. Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type. Am J Pathol. 1993 Jan;142(1):285–292. [PMC free article] [PubMed] [Google Scholar]
  27. Hussell T., Isaacson P. G., Crabtree J. E., Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet. 1993 Sep 4;342(8871):571–574. doi: 10.1016/0140-6736(93)91408-e. [DOI] [PubMed] [Google Scholar]
  28. Hussell T., Isaacson P. G., Spencer J. Proliferation and differentiation of tumour cells from B-cell lymphoma of mucosa-associated lymphoid tissue in vitro. J Pathol. 1993 Feb;169(2):221–227. doi: 10.1002/path.1711690208. [DOI] [PubMed] [Google Scholar]
  29. Isaacson P. G. Gastrointestinal lymphoma. Hum Pathol. 1994 Oct;25(10):1020–1029. doi: 10.1016/0046-8177(94)90060-4. [DOI] [PubMed] [Google Scholar]
  30. Isaacson P. G. Pathogenesis and early lesions in extranodal lymphoma. Toxicol Lett. 1993 Apr;67(1-3):237–247. doi: 10.1016/0378-4274(93)90059-7. [DOI] [PubMed] [Google Scholar]
  31. Isaacson P. G., Wotherspoon A. C., Diss T., Pan L. X. Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Surg Pathol. 1991 Sep;15(9):819–828. doi: 10.1097/00000478-199109000-00001. [DOI] [PubMed] [Google Scholar]
  32. Johnson P. W., Watt S. M., Betts D. R., Davies D., Jordan S., Norton A. J., Lister T. A. Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood. 1993 Sep 15;82(6):1848–1857. [PubMed] [Google Scholar]
  33. Kindler V., Matthes T., Jeannin P., Zubler R. H. Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking. Eur J Immunol. 1995 May;25(5):1239–1243. doi: 10.1002/eji.1830250516. [DOI] [PubMed] [Google Scholar]
  34. Küppers R., Zhao M., Hansmann M. L., Rajewsky K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J. 1993 Dec 15;12(13):4955–4967. doi: 10.1002/j.1460-2075.1993.tb06189.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Liu Y. J., Malisan F., de Bouteiller O., Guret C., Lebecque S., Banchereau J., Mills F. C., Max E. E., Martinez-Valdez H. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity. 1996 Mar;4(3):241–250. doi: 10.1016/s1074-7613(00)80432-x. [DOI] [PubMed] [Google Scholar]
  36. MacLennan I. C. Germinal centers. Annu Rev Immunol. 1994;12:117–139. doi: 10.1146/annurev.iy.12.040194.001001. [DOI] [PubMed] [Google Scholar]
  37. Malisan F., Fluckiger A. C., Ho S., Guret C., Banchereau J., Martinez-Valdez H. B-chronic lymphocytic leukemias can undergo isotype switching in vivo and can be induced to differentiate and switch in vitro. Blood. 1996 Jan 15;87(2):717–724. [PubMed] [Google Scholar]
  38. Marin M. C., Hsu B., Stephens L. C., Brisbay S., McDonnell T. J. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo. Exp Cell Res. 1995 Apr;217(2):240–247. doi: 10.1006/excr.1995.1083. [DOI] [PubMed] [Google Scholar]
  39. Miyazaki T., Liu Z. J., Kawahara A., Minami Y., Yamada K., Tsujimoto Y., Barsoumian E. L., Permutter R. M., Taniguchi T. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell. 1995 Apr 21;81(2):223–231. doi: 10.1016/0092-8674(95)90332-1. [DOI] [PubMed] [Google Scholar]
  40. Morikawa Y., Tohya K., Ishida H., Matsuura N., Kakudo K. Different migration patterns of antigen-presenting cells correlate with Th1/Th2-type responses in mice. Immunology. 1995 Aug;85(4):575–581. [PMC free article] [PubMed] [Google Scholar]
  41. Morio T., Hanissian S., Geha R. S. Characterization of a 23-kDa protein associated with CD40. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11633–11636. doi: 10.1073/pnas.92.25.11633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ott G., Kirchner T., Seidl S., Müller-Hermelink H. K. Primary gastric lymphoma is rarely associated with Epstein-Barr virus. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;64(5):287–291. doi: 10.1007/BF02915124. [DOI] [PubMed] [Google Scholar]
  43. Qin Y., Greiner A., Trunk M. J., Schmausser B., Ott M. M., Müller-Hermelink H. K. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood. 1995 Nov 1;86(9):3528–3534. [PubMed] [Google Scholar]
  44. Racke M. K., Bonomo A., Scott D. E., Cannella B., Levine A., Raine C. S., Shevach E. M., Röcken M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med. 1994 Nov 1;180(5):1961–1966. doi: 10.1084/jem.180.5.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Radaszkiewicz T., Dragosics B., Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology. 1992 May;102(5):1628–1638. doi: 10.1016/0016-5085(92)91723-h. [DOI] [PubMed] [Google Scholar]
  46. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol. 1994;12:227–257. doi: 10.1146/annurev.iy.12.040194.001303. [DOI] [PubMed] [Google Scholar]
  47. Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D. H., Kastelein R., Moore K. W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1890–1893. doi: 10.1073/pnas.89.5.1890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Schmid I., Krall W. J., Uittenbogaart C. H., Braun J., Giorgi J. V. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry. 1992;13(2):204–208. doi: 10.1002/cyto.990130216. [DOI] [PubMed] [Google Scholar]
  49. Wotherspoon A. C., Doglioni C., Diss T. C., Pan L., Moschini A., de Boni M., Isaacson P. G. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993 Sep 4;342(8871):575–577. doi: 10.1016/0140-6736(93)91409-f. [DOI] [PubMed] [Google Scholar]
  50. Wotherspoon A. C., Finn T. M., Isaacson P. G. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood. 1995 Apr 15;85(8):2000–2004. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES